1-6 of 6
leukemia, myeloid, chronic-phase
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Is there a best TKI for chronic phase CML?

Richard A. Larson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 250–256.
https://doi.org/10.1182/asheducation-2015.1.250
Published: 2015
Journal Articles

Goals for chronic myeloid leukemia TK inhibitor treatment: how little disease is too much?

Michael J. Mauro
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 234–239.
https://doi.org/10.1182/asheducation-2014.1.234
Published: 2014
Journal Articles

Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance

Dale Bixby, Moshe Talpaz
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 461–476.
https://doi.org/10.1182/asheducation-2009.1.461
Published: 2009
Journal Articles

Chronic Myeloid Leukemia Stem Cells

Catriona H. Jamieson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 436–442.
https://doi.org/10.1182/asheducation-2008.1.436
Published: 2008
Journal Articles

ABL Kinase Inhibitor Therapy for CML: Baseline Assessments and Response Monitoring

Timothy Hughes
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 211–218.
https://doi.org/10.1182/asheducation-2006.1.211
Published: 2006
Journal Articles

Chronic Myelogenous Leukemia: Disease Biology and Current and Future Therapeutic Strategies

Hagop Kantarjian, Junia V. Melo, Sante Tura, Sergio Giralt, Moshe Talpaz
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2000) 2000 (1): 90–109.
https://doi.org/10.1182/asheducation.V2000.1.90.90
Published: 2000